PharmiWeb.com - Global Pharma News & Resources
22-Jul-2019

Spatial Genomics and Transcriptomics Market Will Grow 8.7% to a Record $ 270 Million by 2026

The Global Spatial Genomics and Transcriptomics Market Size is anticipated to around USD 270 Million by 2026, this market is anticipated to grow with 8.7% CAGR during the forecast time period 2019 to 2026. Acumen Research and Consulting recently published a report titled ldquo;Spatial Genomics and Transcriptomics Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026rdquo;.

Current developments in genetic instruments as well as increasing investment in genomics and transcriptomic research are important drivers of market growth in cumulative demand for robust diagnostic alternatives for cancer. In addition, new and start-up genomic businesses are working to meet the growing demand for sophisticated methods to study spatial patterns through new goods.

For instance, GeoMx Digitally Spatial Profiler is planned for 2019 by NanoString Technologies. Furthermore, companies are involved in strategic alliances to capitalize on unexploited market opportunities. A partnership was entered into in April 2017 between Spatial Transcriptomics and Seven Bridges to develop a sophisticated visualizational tool to monitor gene expression within tissue samples.

In disease management, spatial genomics has excellent potential as it assists in providing quantitative genetic expression information, together with visualized DNA amp; RNA mapping within parts of the tissue. In turn, this generates profitable possibilities for companies to introduce spatially resolved diagnostic and translational research transcriptomics and Genomics-based techniques.

Download Free Sample Report Pages for Better understanding at https://www.acumenresearchandconsulting.com/request-sample/1532

Key Highlights

Advances in instruments for genome disruption fuel the adoption of FISH and thus lead to the biggest share of technology income. On the other side, massive parallel sequencing leads to an increase in output at low costs and the segment progression is expected to soon be supplemented by fast CAGR.

The large available sequence platforms that support the research of RNA architecture in tissue or cells were important for spatial transcriptomics. However, IHC methods are anticipated to experience the highest market penetration as they are not very well suited to spatial omics research, but low in performance sequencing.

Due to elevated penetration of products and the broad accessibility of reagents and kits for conducting studies, consumables were the biggest share in revenues. In parallel, strategic partners between players, such as the purchase of Illumina's Edico Genome in May 2018 to speed up the genomic information assessment, lead to a greater software product development rate.

In translation studies, spatial genomics and transcriptomics were the biggest share of income in 2018. Key suppliers give scientists multiple platforms for assessment in genomic studies, access and boost income generation for large-scale biomedical information. Current research into the morphologic state of cells while diagnoses of illnesses gives university clients potential opportunities for market growth.

North America dominated the space genomics and transcriptomics market and is anticipated to proceed with its biggest sales share in 2018. Massive investment in cancer research is attributable to the great demand for sophisticated diagnostic and therapy techniques in the United States.

The highest development in Asia Pacific is anticipated during the forecast period. Increasing the geographical expansion of firms from established areas are fitted with cheap manufacturing amp; operating units in developing economies in the area.

Spatial genomics and transcriptomics allow researchers not only to see what is in a cell but also how cells are organized in relation to each other to offer invaluable insights into an illness through the use of data which were previously beyond the reach of modern methods. Spatial genomics amp; transcriptomics includes transcriptomic exploration and assortment.

Key Players amp; Strategies

Some of the key participants operating in this market are NanoString Technologies; 10x Genomics; CARTANA AB; Horizon Discovery Group plc; Illumina, Inc.;S2 Genomics, Inc.; Dovetail Genomics; Seven Bridges Genomic; and Advanced Cell Diagnostics.

Mature players are engaged in developing new platforms in order to preserve their place on the market. Government funding helps new players to expand their product range. For example, the PhaseI STTR grant for the development of a singulator system to automate the preparation of single kernels was awarded by S2 Genomics in June 2018 from the national Institute of Health.

View Detailed Information at https://www.acumenresearchandconsulting.com/spatial-genomics-and-transcriptomics-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Spatial Genomics and Transcriptomics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Spatial Genomics and Transcriptomics Market By Technology
1.2.2.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Spatial Genomics and Transcriptomics Market Revenue Share By Technology in 2017
1.2.2.3. Spatial Transcriptomics
1.2.2.3.1. Sequencing-Based Methods
1.2.2.3.1.1. In Situ Sequencing
1.2.2.3.1.2. Laser Capture Microdissection (LCM)
1.2.2.3.1.3. Microtomy Sequencing
1.2.2.3.1.4. Transcriptome In-Vivo Analysis (TIVA)
1.2.2.3.2. Microscopy-based RNA Imaging Techniques
1.2.2.3.2.1. Padlock Probes/ Rolling Circle Amplification
1.2.2.3.2.2. Single Molecule RNA Fluorescence In-Situ Hybridization
1.2.2.3.2.3. Branched DNA Probes
1.2.2.3.3. IHC
1.2.2.4. Spatial Genomics
1.2.2.4.1. Microscopy-based Live DNA Imaging
1.2.2.4.2. FISH
1.2.2.4.3. Massively-Parallel Sequencing
1.2.2.4.4. Genome Perturbation Tools
1.2.2.4.5. Biochemical Techniques
1.2.2.4.6. Others
1.2.3. Spatial Genomics and Transcriptomics Market By Product
1.2.3.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.3.2. Instruments
1.2.3.2.1. By Type
1.2.3.2.1.1. IHC
1.2.3.2.1.2. Sequencing Platforms
1.2.3.2.1.3. Mass Spectrometry
1.2.3.2.1.4. Microscopy
1.2.3.2.1.5. Flow Cytometry
1.2.3.2.1.6. Others
1.2.3.2.2. By Mode
1.2.3.2.2.1. Manual
1.2.3.2.2.2. Semi-automated
1.2.3.2.2.3. Automated
1.2.3.3. Software
1.2.3.3.1. Imaging Tools
1.2.3.3.2. Bioinformatics Tools
1.2.3.3.3. Storage and Management Databases
1.2.3.4. Consumables
1.2.4. Spatial Genomics and Transcriptomics Market By End-Use
1.2.4.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
1.2.4.2. Pharmaceutical Manufacturer
1.2.4.3. Academic Customers
1.2.4.4. Translational Research
1.2.4.5. Diagnostic Customers
1.2.4.6. Others
1.2.5. Spatial Genomics and Transcriptomics Market by Geography
1.2.5.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017

CHAPTER 4. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY TECHNOLOGY

4.1. Global Spatial Genomics and Transcriptomics Revenue By Technology
4.2. Spatial Transcriptomics
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Sequencing-Based Methods
4.2.3.1. In Situ Sequencing
4.2.3.2. Laser Capture Microdissection (LCM)
4.2.3.3. Microtomy Sequencing
4.2.3.4. Transcriptome In-Vivo Analysis (TIVA)
4.2.4. Microscopy-based RNA Imaging Techniques
4.2.4.1. Padlock Probes/ Rolling Circle Amplification
4.2.4.2. Single Molecule RNA Fluorescence In-Situ Hybridization
4.2.4.3. Branched DNA Probes
4.2.5. IHC
4.3. Spatial Genomics
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Microscopy-based Live DNA Imaging
4.3.4. FISH
4.3.5. Massively-Parallel Sequencing
4.3.6. Genome Perturbation Tools
4.3.7. Biochemical Techniques
4.3.8. Others

CHAPTER 5. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY PRODUCT

5.1. Global Spatial Genomics and Transcriptomics Revenue By Product
5.2. Instruments
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.2.3. By Type
5.2.3.1. IHC
5.2.3.2. Sequencing Platforms
5.2.3.3. Mass Spectrometry
5.2.3.4. Microscopy
5.2.3.5. Flow Cytometry
5.2.3.6. Others
5.2.4. By Mode
5.2.4.1. Manual
5.2.4.2. Semi-automated
5.2.4.3. Automated
5.3. Software
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3.3. Imaging Tools
5.3.4. Bioinformatics Tools
5.3.5. Storage and Management Databases
5.4. Consumables
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY END-USE

6.1. Global Spatial Genomics and Transcriptomics Revenue By End-Use
6.2. Pharmaceutical Manufacturer
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Academic Customers
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Translational Research
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Diagnostic Customers
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

7.1. North America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. Spatial Genomics and Transcriptomics Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

8.1. Europe Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

9.1. Asia-Pacific Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

10.1. Latin America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

11.1. Middle East Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

12.1. Africa Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. NanoString Technologies
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. 10x Genomics
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. CARTANA AB
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Horizon Discovery Group plc
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Illumina, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. S2 Genomics, Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Dovetail Genomics
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Seven Bridges Genomic
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Advanced Cell Diagnostics
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Request for Customization at https://www.acumenresearchandconsulting.com/request-customization/1532

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1532

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise

Editor Details

Last Updated: 22-Jul-2019